{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:58:52Z","timestamp":1740110332878,"version":"3.37.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI124006"],"award-info":[{"award-number":["R01AI124006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.05.014","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:46:54Z","timestamp":1559249214000},"page":"156-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8+ T cell responses in na\u00efve and persistently infected mice and protects from challenge"],"prefix":"10.1016","volume":"168","author":[{"given":"Carolina","family":"Chiale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiehkhatoon","family":"Moshkani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Robek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.05.014_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0818-9641.2004.01278.x","article-title":"Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen","volume":"82","author":"Aguilar","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/CVI.00451-08","article-title":"Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus","volume":"16","author":"Barefoot","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib3","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1073\/pnas.88.23.10445","article-title":"HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen","volume":"88","author":"Bertoletti","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.014_bib4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.29239","article-title":"Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice","volume":"66","author":"Bian","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.05.014_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173352","article-title":"Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice","volume":"12","author":"Chapman","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.014_bib6","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.014_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-006-0042-3","article-title":"Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector","volume":"28","author":"Clarke","year":"2006","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib9","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.01911-06","article-title":"Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations","volume":"81","author":"Clarke","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib10","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1128\/JVI.00200-10","article-title":"A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose","volume":"84","author":"Cobleigh","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib11","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/JVI.05991-11","article-title":"The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate","volume":"86","author":"Cobleigh","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib12","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/JVI.02111-12","article-title":"A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice","volume":"87","author":"Cobleigh","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice","volume":"82","author":"Cooper","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib14","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection","volume":"205","author":"Das","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.014_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coviro.2018.04.003","article-title":"Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccination","volume":"30","author":"Dembek","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2019.05.014_bib16","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coviro.2018.03.006","article-title":"Why, who and when to start treatment for chronic hepatitis B infection","volume":"30","author":"Dolman","year":"2018","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2019.05.014_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202753","article-title":"Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial","volume":"13","author":"Elizaga","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.05.014_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral vectors as vaccine platforms: from immunogenicity to impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/gutjnl-2013-305707","article-title":"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN","volume":"64","author":"Fontaine","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.05.014_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jviromet.2005.03.001","article-title":"Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control","volume":"126","author":"Garson","year":"2005","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.antiviral.2019.05.014_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1345717","article-title":"The molecular virology of hepatitis B virus","volume":"33","author":"Glebe","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2019.05.014_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Grimm","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.antiviral.2019.05.014_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib25","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","article-title":"Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme","volume":"83","author":"Ito","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1128\/JVI.02020-06","article-title":"Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo","volume":"81","author":"Keasler","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib27","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1128\/JVI.00506-12","article-title":"DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model","volume":"86","author":"Kosinska","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003391","article-title":"Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model","volume":"9","author":"Kosinska","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.014_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2019.05.014_bib30","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.4049\/jimmunol.156.10.3687","article-title":"DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice","volume":"156","author":"Kuhober","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00263-17","article-title":"DNA priming increases frequency of T-cell responses to a vesicular stomatitis virus HIV vaccine with specific enhancement of CD8(+) T-cell responses by interleukin-12 plasmid DNA","volume":"24","author":"Li","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2019.05.014_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","author":"Liu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.05.014_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2468-1253(18)30007-4","article-title":"Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand","volume":"3","author":"Maini","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.antiviral.2019.05.014_bib35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1136\/gutjnl-2014-308041","article-title":"TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice","volume":"64","author":"Martin","year":"2015","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2019.05.014_bib36","doi-asserted-by":"crossref","first-page":"S443","DOI":"10.1093\/infdis\/jiv316","article-title":"Vaccination with a highly attenuated recombinant vesicular stomatitis virus vector protects against challenge with a lethal dose of ebola virus","volume":"212","author":"Matassov","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.05.014_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JVI.71.1.65-74.1997","article-title":"Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope","volume":"71","author":"Menne","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1074\/jbc.M207634200","article-title":"Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences","volume":"278","author":"Messageot","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.014_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.patbio.2010.01.006","article-title":"Hepatitis B vaccines: protective efficacy and therapeutic potential","volume":"58","author":"Michel","year":"2010","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib40","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.05.014_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01586-18","article-title":"A highly attenuated vesicular stomatitis virus-based vaccine platform controls hepatitis B virus replication in mouse models of hepatitis B","volume":"93","author":"Moshkani","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.05.014_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4419-5632-3_7","article-title":"Strategies and implications for prime-boost vaccination to generate memory CD8 T cells","volume":"780","author":"Nolz","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib44","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2(high) tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.014_bib45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0168-8278(01)00028-9","article-title":"Efficacy and limitations of a specific immunotherapy in chronic hepatitis B","volume":"34","author":"Pol","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib46","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1128\/JVI.79.24.15043-15053.2005","article-title":"A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals","volume":"79","author":"Ramsburg","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.181.3.1047","article-title":"The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis","volume":"181","author":"Rehermann","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.05.014_bib48","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI118592","article-title":"Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection","volume":"97","author":"Rehermann","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2019.05.014_bib49","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.01184-15","article-title":"Virus-like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection","volume":"89","author":"Reynolds","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4939-6700-1_20","article-title":"An ELISPOT-based assay to measure HBV-specific CD8(+) T cell responses in immunocompetent mice","volume":"1540","author":"Reynolds","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0092-8674(94)90258-5","article-title":"Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA","volume":"79","author":"Rolls","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.05.014_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/viro.1996.0211","article-title":"Expression of additional genes in a vector derived from a minimal RNA virus","volume":"218","author":"Rolls","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.014_bib53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.05.014_bib54","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.0800280105","article-title":"Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors","volume":"105","author":"Rose","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.014_bib55","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1073\/pnas.1414991111","article-title":"In vitro evolution of high-titer, virus-like vesicles containing a single structural protein","volume":"111","author":"Rose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.05.014_bib56","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/JVI.00342-11","article-title":"Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen","volume":"85","author":"Schell","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib57","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/eji.200324125","article-title":"Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen","volume":"33","author":"Schirmbeck","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib58","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0021-9258(18)54079-5","article-title":"Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly","volume":"268","author":"Schodel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.014_bib59","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.05.014_bib60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/348213a0","article-title":"Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule","volume":"348","author":"Van Bleek","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.05.014_bib61","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/erv.09.121","article-title":"Use of hepadnavirus core proteins as vaccine platforms","volume":"8","author":"Whitacre","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2019.05.014_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2019.05.014_bib63","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1074\/jbc.M208895200","article-title":"Kinetics of synthesis and turnover of the duck hepatitis B virus reverse transcriptase","volume":"278","author":"Yao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.05.014_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0042-6822(03)00142-9","article-title":"The duck hepatitis B virus polymerase and core proteins accumulate in different patterns from their common mRNA","volume":"311","author":"Yao","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.014_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2014.11.004","article-title":"Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects","volume":"475","author":"Zhang","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.05.014_bib66","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1080\/21645515.2017.1344797","article-title":"Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model","volume":"13","author":"Zhao","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2019.05.014_bib67","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.1502061","article-title":"Clearing persistent extracellular antigen of hepatitis B virus: an immunomodulatory strategy to reverse tolerance for an effective therapeutic vaccination","volume":"196","author":"Zhu","year":"2016","journal-title":"J. Immunol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T02:16:35Z","timestamp":1694916995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":67,"alternative-id":["S0166354219301603"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8+ T cell responses in na\u00efve and persistently infected mice and protects from challenge","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}